C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 231/12 (2006.01) A61K 31/415 (2006.01)
Patent
CA 2566846
A new class of phosphoinositide-dependent kinase-1 (PDK-1) inhibitors of formula (I): wherein X is selected from the group consisting of alkyl and haloalkyl; Ar is an aryl radical selected from the group consisting of phenyl, biphenyl, naphthyl, anthryl, phenanthryl, and fluorenyl; and wherein Ar is optionally substituted with one or more radicals selected from the group consisting of halo, C1 C4 alkyl, C1 C4 haloalkyl, azido, C1 C4 azidoalkyl, aryl, akylaryl, haloaryl, haloalkylaryl, and combinations thereof; and R is selected from the group consisting of nitrile, acetonitrile, ethylnitrile, propylnitrile, carboxamide, amidine, tetrazole, oxime, hydrazone, acetamidine, aminoacetamide, guanidine, and urea. Also provided are methods of using the compounds for the treatment and prevention of cancer in humans.
Nouvelle classe d'inhibiteurs de kinase-1 dépendant de phosphoïnositide (PDK-1) ayant la formule (I) dans laquelle X est sélectionné dans le groupe comprenant alkyle et haloalkyle; Ar est un radical aryle sélectionné dans le groupe comprenant phényle, biphényle, naphthyle, anthryle, phénanthryle et fluorényle; et dans lequel Ar est éventuellement substitué par un ou plusieurs radicaux sélectionnés dans le groupe comprenant halo, alkyle C¿1? C¿4?, haloalkyle C¿1? C¿4?, azido, azidoalkyle C¿1? C¿4?, aryle, akylaryle, haloaryle, haloalkylaryle et leurs combinaisons; et R est sélectionné dans le groupe constitué de nitrile, acétonitrile, éthylnitrile, propylnitrile, carboxamide, amidine, tétrazole, oxime, hydrazone, acetamidine, aminoacetamide, guanidine et urée. L'invention concerne aussi des procédés pour utiliser ces composés dans le traitement et la prévention du cancer chez les humains.
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
The Ohio State University Research Foundation
LandOfFree
Pdk-1/akt signaling inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pdk-1/akt signaling inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pdk-1/akt signaling inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1741880